New insights into the management of anemia in the surgical patient

American Journal of Medicine

Volumn 101, Issue 2 A, 1996, Pages 12S-15S

  Klein, Harvey G ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; BLOOD TRANSFUSION; CANCER PATIENT; CONFERENCE PAPER; DISEASE TRANSMISSION; GRAFT SURVIVAL; HUMAN; IMMUNOMODULATION; INFECTION RISK; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SURGICAL PATIENT; IRON DEFICIENCY ANEMIA; REVIEW; SURGERY;

ANEMIA, HYPOCHROMIC; BLOOD TRANSFUSION; HUMANS; SURGICAL PROCEDURES, OPERATIVE;

EID: 85048352893     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(96)00162-3     Document Type: Conference Paper

References (23)

1. Schreiber GB, Busch MP, Akinman S, et al. The risk of transfusion-transmitted viral infections. N Engl J Med. 1996;334:1685-1690.
2. Simons JN, Pilot-Matias TJ, Lear TP, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA. 1995;92:3401-3405.
3. Centers for Disease Control Update. MMWR. 1991;40:176-178.
4. Stehling LC, Cosgrove DM, Moss GS, et al. Indications for the use of red blood cells, platelets, and fresh frozen plasma. US Department of Health and Human Services Publication (NIH) 89-2974. Bethesda, MD: 1989.
5. Linden JV, Paul B, Dressler KP. A report of 104 transfusion errors in New York State. Transfusion. 1992;32:601-606.
6. Opelz G, Terasaki PI. Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med. 1978;299:799-803.
7. Lagaaij EL, Hennemann IPH, Ruigrok M, et al. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med. 1989;321:701-705.
8. Burrows L, Tartter PI. Effect of blood transfusions on colonic malignancy recurrence rate. (Letter.) Lancet. 1982;ii:662.
9. Rosenberg SA, Seipp CA, White DE, et al. Perioperative blood transfusions are associated with increased rates of recurrence and decreased survival in patients with high-grade soft-tissue sarcomas of the extremities. J Clin Oncol. 1985;3:698-709.
10. Busch OR, Hop WC, Hoynck van Papendrecht MA, et al. Blood transfusions and prognosis in colorectal cancer. N Engl J Med. 1993;328:1372-1376.
11. Blumberg N, Heal JM. Transfusion and host defenses against cancer recurrence and infection. Transfusion. 1988;29:236-245.
12. Murphy P, Heal JM, Blumberg N. Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion. 1991;31:212-217.
13. Heiss MM, Mempel W, Jauch K-W, et al. A blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer. J Clin Oncol. 1994;12:1859-1867.
14. Jensen LS, Andersen AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg. 1992;79:513-516.
15. Heiss MM, Mempel W, Jauch K-W, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet. 1993;342:1328-1333.
16. Whyte BM, Swanson CE, Cooper DA. Survival of patients with the acquired immunodeficiency syndrome in Australia. Med J Aust. 1989;150:358-362.
17. Ward JW, Bush TJ, Perkins HA, et al. The natural history of transfusion-associated infection with human immunodeficiency virus: factors influencing the rate of progression to disease. N Engl J Med. 1989;321:947-952.
18. Vamvakas E, Kaplan HS. Early transfusion and length of survival in acquired immune deficiency syndrome: experience with a population receiving medical care at a public hospital. Transfusion. 1993;33:111-118.
19. Sloand E, Kumar P, Klein HG, et al. Transfusion of blood products in HIV-1 infected persons: relationship to opportunistic infection. Transfusion. 1994;48:168-172.
20. Busch MP, Lee TH, Heitman J. Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients. Blood. 1992;80:2128-2135.
21. Taylor C, Faulk WP. Prevention of recurrent abortion with leucocyte transfusions. Lancet. 1981;ii:68-70.
22. Mowbray JF, Gibbings C, Lidell H, et al. Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet. 1985;i:941-943.
23. Williams JG, Hughes LE. Effect of perioperative blood transfusion on recurrence of Crohn's disease. (Letter.) Lancet. 1989;ii:1524.